Literature DB >> 32712605

Impaired Cognitive Flexibility and Working Memory Precedes Depression: A Rat Model to Study Depression.

Margarita M Maramis1, Marlina S Mahajudin2, Junaidi Khotib3.   

Abstract

INTRODUCTION: Depressive disorders are the 4th leading cause of health problems and the 2nd leading cause of burden among all diseases. Almost all depressive disorder patients have cognitive impairments to a certain extend. Studies about cognitive impairments in depression had been conducted, but whether cognitive dysfunctions are the cause or the effect is still not clear.
OBJECTIVES: To analyze the process of working memory and cognitive flexibility impairments in a rat model of depression.
METHODS: In this experimental study, chronic unpredictable mild stress (CUMS) was used as a model of depression in 30 rats (Rattus novergicus). Cognitive function was assessed with the Morris water maze and attentional set shifting test.
RESULTS: This study found a significant difference on day 21 in working memory (p = 0.002) and cognitive flexibility (p = 0.036), which continued to day 41 in working memory (p = 0.001) and cognitive flexibility (p = 0.020). In the CUMS model of depression, parameters peak on day 41 and reveal parameter changes in weight gain (p = 0.018), food intake (p < 0.001), changes in food intake (p = 0.001), and the sucrose preference (p = 0.005), elevated plus maze (p = 0.001), and light dark box tests (p = 0.020).
CONCLUSION: In a rat model of depression, cognitive impairment preceded depression, but it might be caused by anxiety-like behavior that occurred in early stimulation of chronic unpredictable mild stress. The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Cognitive impairment; Correlation of time; Depression

Year:  2020        PMID: 32712605      PMCID: PMC8220918          DOI: 10.1159/000508682

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  55 in total

1.  Neurocognition in depression: patients on and off medication versus healthy comparison subjects.

Authors:  C Thomas Gualtieri; Lynda G Johnson; Kenneth B Benedict
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2006       Impact factor: 2.198

Review 2.  Models of depression.

Authors:  Catharine H Duman
Journal:  Vitam Horm       Date:  2010       Impact factor: 3.421

3.  Depression and quality of life: results of a follow-up study.

Authors:  M C Angermeyer; A Holzinger; H Matschinger; K Stengler-Wenzke
Journal:  Int J Soc Psychiatry       Date:  2002-09

Review 4.  Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field.

Authors:  K W Miskowiak; C V Ott; J Z Petersen; L V Kessing
Journal:  Eur Neuropsychopharmacol       Date:  2016-10-14       Impact factor: 4.600

5.  Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour.

Authors:  S L Handley; S Mithani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-08       Impact factor: 3.000

6.  Cognitive bias and depression in psychiatrically disturbed children and adolescents.

Authors:  G M Haley; S Fine; K Marriage; M M Moretti; R J Freeman
Journal:  J Consult Clin Psychol       Date:  1985-08

7.  A comparison of neurocognitive impairment in younger and older adults with major depression.

Authors:  A J Thomas; P Gallagher; L J Robinson; R J Porter; A H Young; I N Ferrier; J T O'Brien
Journal:  Psychol Med       Date:  2008-07-30       Impact factor: 7.723

8.  Cognitive flexibility is associated with KIBRA variant and modulated by recent tobacco use.

Authors:  Huiping Zhang; Henry R Kranzler; James Poling; Jeffrey R Gruen; Joel Gelernter
Journal:  Neuropsychopharmacology       Date:  2009-07-15       Impact factor: 7.853

Review 9.  The association between cognitive function and subsequent depression: a systematic review and meta-analysis.

Authors:  M A Scult; A R Paulli; E S Mazure; T E Moffitt; A R Hariri; T J Strauman
Journal:  Psychol Med       Date:  2016-09-14       Impact factor: 7.723

Review 10.  Cognitive impairment in depression: recent advances and novel treatments.

Authors:  Giulia Perini; Matteo Cotta Ramusino; Elena Sinforiani; Sara Bernini; Roberto Petrachi; Alfredo Costa
Journal:  Neuropsychiatr Dis Treat       Date:  2019-05-10       Impact factor: 2.570

View more
  3 in total

1.  Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.

Authors:  Manoj K Doss; Michal Považan; Monica D Rosenberg; Nathan D Sepeda; Alan K Davis; Patrick H Finan; Gwenn S Smith; James J Pekar; Peter B Barker; Roland R Griffiths; Frederick S Barrett
Journal:  Transl Psychiatry       Date:  2021-11-08       Impact factor: 6.222

2.  The neural correlates of interference control dysfunction of working memory in major depressive disorder: An event-related potential study.

Authors:  Sha-Yu Jin; Jia-Zhao Zhang; Ru-Hong Sun; Chen-Guang Jiang; Jun Wang; Zhen-He Zhou
Journal:  Front Psychiatry       Date:  2022-09-30       Impact factor: 5.435

3.  Effect of Epigallocatechin-3-gallate on Stress-Induced Depression in a Mouse Model: Role of Interleukin-1β and Brain-Derived Neurotrophic Factor.

Authors:  Nabila E Abdelmeguid; Tasneem M Hammad; Ashraf M Abdel-Moneim; Sherine Abdel Salam
Journal:  Neurochem Res       Date:  2022-08-08       Impact factor: 4.414

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.